Aterian Inc (ATER) Stock Price, Quote & News

Latest News on ATER

May 14, 2025, 6:02 PM EDT - 23 days ago

Aterian, Inc. (ATER) Q1 2025 Earnings Call Transcript

May 14, 2025, 4:05 PM EDT - 23 days ago

Aterian Reports 2025 First Quarter Financial Results

May 5, 2025, 4:15 PM EDT - 4 weeks ago

Aterian Sets Date for First Quarter 2025 Earnings Announcement & Investor Conference Call

Mar 18, 2025, 8:49 PM EDT - 2 months ago

Aterian, Inc. (ATER) Q4 2024 Earnings Call Transcript

Mar 18, 2025, 4:06 PM EDT - 2 months ago

Aterian Reports Fourth Quarter & Full Year 2024 Results

Mar 18, 2025, 4:05 PM EDT - 2 months ago

Aterian Announces Share Repurchase Program

Mar 6, 2025, 8:00 AM EST - 3 months ago

Aterian Sets Date for Fourth Quarter & Full Year 2024 Earnings Announcement & Investor Conference Call

Feb 20, 2025, 8:00 AM EST - 3 months ago

Aterian Issues Letter to Shareholders

Nov 11, 2024, 7:08 PM EST - 7 months ago

Aterian, Inc. (ATER) Q3 2024 Earnings Call Transcript

Nov 11, 2024, 4:15 PM EST - 7 months ago

Aterian Reports Third Quarter 2024 Results

Nov 4, 2024, 10:37 AM EST - 7 months ago

Aterian's Prospects Are Improving Under New Leadership - Buy

Oct 28, 2024, 8:00 PM EDT - 7 months ago

Aterian Sets Date for Third Quarter 2024 Earnings Announcement & Investor Conference Call

Aug 9, 2024, 1:55 PM EDT - 10 months ago

Aterian, Inc. (ATER) Q2 2024 Earnings Call Transcript

Jul 29, 2024, 10:30 AM EDT - 11 months ago

Aterian Sets Date for Second Quarter 2024 Earnings Announcement & Investor Conference Call

Jun 27, 2024, 8:55 AM EDT - 1 year ago

Aterian: Cheap, But Speculative Turnaround Play - Upgrade To Buy

Jun 26, 2024, 4:30 PM EDT - 1 year ago

Aterian Announces Leadership Changes & Improved Second Quarter 2024 Net Revenue and Adjusted EBITDA Ranges

Jun 6, 2024, 9:00 AM EDT - 1 year ago

Aterian Investment Partners Acquires Contract Pharmaceuticals Limited

May 7, 2024, 8:18 PM EDT - 1 year ago

Aterian, Inc. (ATER) Q1 2024 Earnings Call Transcript

May 7, 2024, 4:15 PM EDT - 1 year ago

Aterian Reports First Quarter 2024 Results

Apr 25, 2024, 6:37 PM EDT - 1 year ago

Aterian Sets Date for First Quarter 2024 Earnings Announcement & Investor Conference Call

Apr 22, 2024, 7:30 AM EDT - 1 year ago

Aterian Announces Improved First Quarter 2024 Net Revenue and Adjusted EBITDA Ranges

Apr 1, 2024, 11:25 AM EDT - 1 year ago

Aterian Investment Partners to Recapitalize CPL, a Leading Pharmaceutical Contract Development and Manufacturing Organization

Mar 20, 2024, 7:30 AM EDT - 1 year ago

Aterian Announces Reverse Stock Split

Mar 12, 2024, 9:30 PM EDT - 1 year ago

Aterian, Inc. (ATER) Q4 2023 Earnings Call Transcript

Mar 12, 2024, 4:15 PM EDT - 1 year ago

Aterian Reports Fourth Quarter & Full Year 2023 Results

Mar 7, 2024, 4:30 PM EST - 1 year ago

Aterian Makes Strategic Minority Equity Investment in 4th & Heart

Feb 29, 2024, 4:30 PM EST - 1 year ago

Aterian Sets Date for Fourth Quarter & Full Year 2023 Earnings Announcement & Investor Conference Call

Feb 26, 2024, 7:30 AM EST - 1 year ago

Aterian Further Strengthens Its Balance Sheet With Extension Of Its Credit Facility

Feb 14, 2024, 4:30 PM EST - 1 year ago

Aterian Announces Fixed Cost Reduction Plan and Preliminary Fourth Quarter 2023 Results

Nov 13, 2023, 8:30 AM EST - 1 year ago

Squatty Potty Re-Launches In Walmart Stores Nationwide

Nov 8, 2023, 7:10 PM EST - 1 year ago

Aterian, Inc. (ATER) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 4:15 PM EST - 1 year ago

Aterian Reports Third Quarter 2023 Results

Oct 27, 2023, 5:30 PM EDT - 1 year ago

Aterian Sets Date for Third Quarter 2023 Earnings Announcement & Investor Conference Call

Oct 24, 2023, 4:50 PM EDT - 1 year ago

Aterian Receives Extension To Regain Compliance With Nasdaq Minimum Bid Price Rule

Aug 8, 2023, 4:15 PM EDT - 1 year ago

Aterian Reports Second Quarter 2023 Results

Aug 1, 2023, 8:45 AM EDT - 2 years ago

Aterian Sets Date for Second Quarter 2023 Earnings Announcement & Investor Conference Call

Jul 31, 2023, 4:20 PM EDT - 2 years ago

Aterian, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Jun 6, 2023, 8:43 PM EDT - 2 years ago

Aterian, Inc.: Downgrading On Substantially Reduced Expectations Amid Weak Consumer Demand

May 9, 2023, 10:32 PM EDT - 2 years ago

Aterian, Inc. (ATER) Q1 2023 Earnings Call Transcript

May 9, 2023, 4:15 PM EDT - 2 years ago

Aterian Reports First Quarter 2023 Results

Apr 27, 2023, 5:00 PM EDT - 2 years ago

Aterian Sets Date for First Quarter 2023 Earnings Announcement & Investor Conference Call

Apr 19, 2023, 7:30 AM EDT - 2 years ago

Aterian Announces Updated First Quarter 2023 Net Revenue and Adjusted EBITDA Ranges

Mar 31, 2023, 4:20 PM EDT - 2 years ago

Aterian, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mar 9, 2023, 11:46 PM EST - 2 years ago

Aterian, Inc. (ATER) Q4 2022 Earnings Call Transcript

Mar 9, 2023, 4:15 PM EST - 2 years ago

Aterian Reports Fourth Quarter & Full Year 2022 Results

Feb 21, 2023, 8:30 AM EST - 2 years ago

Aterian Announces Further Expansion in Europe

Feb 6, 2023, 7:00 AM EST - 2 years ago

Aterian Announces Management Promotions and Changes

Jan 19, 2023, 4:29 AM EST - 2 years ago

Aterian: Paving The Way For An Improved Second Half, Buy

Dec 1, 2022, 4:30 PM EST - 2 years ago

Aterian Announces Strong Cyber Monday Sales

Nov 8, 2022, 11:20 PM EST - 2 years ago

Market Cap	12.25M
Revenue (ttm)	99.05M
Net Income (ttm)	-11.86M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-11.97%
Debt to Equity Ratio	0.02

Volume	109,200
Avg Vol	121,430
Day's Range	N/A - N/A
Shares Out	8.75M
Stochastic %K	5%
Beta	0.37
Analysts	Strong Sell
Price Target	$4.00